Ovarian Cancer Trial, Recruiting (NCT06103916)

Ovarian Cancer Trial, Recruiting NCT06103916 Sponsor: Maxima Medical Center Condition: Ovarian Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06103916 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Ovarian Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged 18 years or older
People who have a complex ovarian tumour (a growth on the ovary that has features requiring further assessment)
People whose ovarian tumour has been assessed by ultrasound using a specific set of medical guidelines and a risk-scoring tool called the ADNEX model (confirm with trial site)
People who can read and understand the Dutch language

Who may not be able to join:

People whose ovarian tumour falls into a "clearly benign" (non-cancerous) category based on specific ultrasound guidelines — this includes tumours that appear to be an endometrioma (a cyst related to endometriosis), a benign cystic teratoma (a type of non-cancerous growth), a simple cyst or cystadenoma smaller than 10cm with smooth walls, or any other single-chambered cyst with regular, smooth walls
People who have already been confirmed through a tissue test (biopsy or surgery) to have a cancerous tumour before the ultrasound assessment takes place

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 6 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +31 40 888 83 80

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06103916

Sponsor: Maxima Medical Center

Phase: Not Applicable

Status: Recruiting

Condition: Ovarian Cancer

Trial contact: +31 40 888 83 80

More information: https://clinicaltrials.gov/study/NCT06103916

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged 18 years or older
People who have a complex ovarian tumour (a growth on the ovary that has features requiring further assessment)
People whose ovarian tumour has been assessed by ultrasound using a specific set of medical guidelines and a risk-scoring tool called the ADNEX model (confirm with trial site)
People who can read and understand the Dutch language

Who may not be able to join:

People whose ovarian tumour falls into a "clearly benign" (non-cancerous) category based on specific ultrasound guidelines — this includes tumours that appear to be an endometrioma (a cyst related to endometriosis), a benign cystic teratoma (a type of non-cancerous growth), a simple cyst or cystadenoma smaller than 10cm with smooth walls, or any other single-chambered cyst with regular, smooth walls
People who have already been confirmed through a tissue test (biopsy or surgery) to have a cancerous tumour before the ultrasound assessment takes place

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 6 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Maxima Medical Center

Registry

ClinicalTrials.gov

Start date

15 July 2022

Est. completion

1 August 2027

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Diagnostic accuracy of the IOTA ADNEX model; Sensitivity and specificity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov